David A. Siegel Liquidia Corp Transaction History

Two Sigma Advisers, LP

$46.1 Billion
Q2 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Liquidia Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 324,400 shares of LQDA stock, worth $7.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

324,400

Previous 287,800 12.72%

Holding current value

$7.27 Million

Previous $4.25 Million 4.78%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$11.99 - $19.3 $438,834 - $706,380	36,600 Added 12.72%	324,400 $4.04 Million
Q1 2025 May 15, 2025	BUY	$11.36 - $16.5 $1.2 Million - $1.75 Million	106,000 Added 58.31%	287,800 $4.25 Million
Q4 2024 Feb 14, 2025	SELL	$9.82 - $11.8 $54,992 - $66,080	-5,600 Reduced 2.99%	181,800 $2.14 Million
Q3 2024 Nov 14, 2024	SELL	$8.9 - $14.11 $600,750 - $952,425	-67,500 Reduced 26.48%	187,400 $1.87 Million
Q2 2024 Aug 14, 2024	SELL	$11.96 - $15.71 $221,260 - $290,635	-18,500 Reduced 6.77%	254,900 $3.06 Million
Q1 2024 May 15, 2024	SELL	$11.35 - $16.73 $299,640 - $441,672	-26,400 Reduced 8.81%	273,400 $4.03 Million
Q4 2023 Feb 14, 2024	SELL	$5.77 - $12.19 $482,948 - $1.02 Million	-83,700 Reduced 21.83%	299,800 $3.61 Million
Q3 2023 Nov 14, 2023	SELL	$6.27 - $8.15 $574,959 - $747,355	-91,700 Reduced 19.3%	383,500 $2.43 Million
Q2 2023 Aug 14, 2023	SELL	$6.63 - $9.9 $651,729 - $973,170	-98,300 Reduced 17.14%	475,200 $3.73 Million
Q1 2023 May 15, 2023	SELL	$5.72 - $7.91 $728,156 - $1.01 Million	-127,300 Reduced 18.16%	573,500 $3.96 Million
Q4 2022 Feb 14, 2023	SELL	$4.68 - $6.54 $1.02 Million - $1.42 Million	-216,900 Reduced 23.64%	700,800 $4.46 Million
Q3 2022 Nov 14, 2022	BUY	$3.73 - $8.39 $1.76 Million - $3.95 Million	471,100 Added 105.49%	917,700 $4.99 Million
Q2 2022 Aug 15, 2022	BUY	$3.37 - $7.55 $706,689 - $1.58 Million	209,700 Added 88.52%	446,600 $1.95 Million
Q1 2022 May 16, 2022	BUY	$5.14 - $7.38 $230,786 - $331,362	44,900 Added 23.39%	236,900 $1.7 Million
Q4 2021 Feb 14, 2022	BUY	$2.71 - $5.17 $520,320 - $992,640	192,000 New	192,000 $935,000
Q4 2020 Feb 16, 2021	SELL	$2.6 - $5.79 $589,160 - $1.31 Million	-226,600 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.34 - $8.28 $828,072 - $1.58 Million	190,800 Added 532.96%	226,600 $1.12 Million
Q2 2020 Aug 14, 2020	BUY	$4.86 - $11.44 $173,988 - $409,552	35,800 New	35,800 $301,000

Others Institutions Holding LQDA

# of Institutions

209

Shares Held

47.5M

Call Options Held

1.61M

Put Options Held

1.15M

View Full List

About Liquidia Corp

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $1.44B
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

More about LQDA

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account